Security key
71880W501
Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO)
CUSIP: 71880W501
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 164,722
- Total 13F value
- $387,355
- Share change
- +64,104
- SEC-reported price per share
- $2.35
- Number of holders
- 11
- Value change
- +$164,978
- Number of buys
- 7
- Number of sells
- 4
- Shares outstanding
- 12,067,869
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
11
Top holders
10
PHIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Phio Pharmaceuticals Corp. SEC filings
Phio Pharmaceuticals Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71880W501
Recent filing periods:
Ownership snapshot
Top reported holders of PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GEODE CAPITAL MANAGEMENT,...
Disclosed value leader
Gerrit Dispersyn
Comparable rows
11/15
Latest evidence
31 Mar 2025
13F
3/4/5
Lead comparable stake: 0.34%
4 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
GEODE CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 0.34%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GEODE CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
GEODE CAPITAL MANAGEMENT, LLC
0.34%
Cetera Investment Advisers
0.32%
XTX Topco Ltd
0.09%
MORGAN STANLEY
0.05%
Tower Research Capital LLC (TRC)
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.34%
|
$54,060
41,586 shares
|
— | 31 Mar 2025 |
| Cetera Investment Advisers |
13F
Company
|
0.32%
|
$50,050
38,500 shares
|
— | 31 Mar 2025 |
| XTX Topco Ltd |
13F
Company
|
0.09%
|
$14,040
10,800 shares
|
— | 31 Mar 2025 |
| MORGAN STANLEY |
13F
Company
|
0.05%
|
$7,800
6,000 shares
|
— | 31 Mar 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.02%
|
$3,251
2,501 shares
|
— | 31 Mar 2025 |
| SBI Securities Co., Ltd. |
13F
Company
|
0.01%
|
$1,258
968 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
164,722
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
10
Q2 2025 holders
11
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend